Does AXICABTAGENE CILOLEUCEL Cause Second primary malignancy? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Second primary malignancy have been filed in association with AXICABTAGENE CILOLEUCEL (YESCARTA). This represents 0.3% of all adverse event reports for AXICABTAGENE CILOLEUCEL.
28
Reports of Second primary malignancy with AXICABTAGENE CILOLEUCEL
0.3%
of all AXICABTAGENE CILOLEUCEL reports
7
Deaths
1
Hospitalizations
How Dangerous Is Second primary malignancy From AXICABTAGENE CILOLEUCEL?
Of the 28 reports, 7 (25.0%) resulted in death, 1 (3.6%) required hospitalization, and 2 (7.1%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXICABTAGENE CILOLEUCEL. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does AXICABTAGENE CILOLEUCEL Cause?
Cytokine release syndrome (4,140)
Immune effector cell-associated neurotoxicity syndrome (1,821)
Neurotoxicity (1,327)
Pyrexia (859)
Death (756)
Disease progression (745)
Hypotension (398)
Neutropenia (391)
Confusional state (299)
Encephalopathy (292)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which AXICABTAGENE CILOLEUCEL Alternatives Have Lower Second primary malignancy Risk?
AXICABTAGENE CILOLEUCEL vs AXITINIB
AXICABTAGENE CILOLEUCEL vs AZACITIDINE
AXICABTAGENE CILOLEUCEL vs AZATHIOPRINE
AXICABTAGENE CILOLEUCEL vs AZD-1222
AXICABTAGENE CILOLEUCEL vs AZELAIC ACID